(Q44368292)

2 December 2017

Uncoupling of protein kinase D from suppression of EGF-dependent c-Jun phosphorylation in cancer cells (English)

1 reference

2 December 2017

1 reference

Cliff Hurd

1

1 reference

PubMed ID

12646240

2 December 2017

Enrique Rozengurt

series ordinal

2

1 reference

PubMed ID

12646240

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Biochemical and Biophysical Research Communications

2 December 2017

1 reference

2 December 2017

302

1 reference

2 December 2017

4

1 reference

2 December 2017

800-804

1 reference

Signal transduction by the JNK group of MAP kinases

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Bombesin, vasopressin, endothelin, bradykinin, and platelet-derived growth factor rapidly activate protein kinase D through a protein kinase C-dependent signal transduction pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Lysophosphatidic acid rapidly induces protein kinase D activation through a pertussis toxin-sensitive pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Cell-type specific phosphorylation of threonines T654 and T669 by PKD defines the signal capacity of the EGF receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Protein kinase D is sufficient to suppress EGF-induced c-Jun Ser 63 phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Protein kinase D complexes with C-Jun N-terminal kinase via activation loop phosphorylation and phosphorylates the C-Jun N-terminus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Protein kinase C (PKC)eta-mediated PKC mu activation modulates ERK and JNK signal pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Protein kinase C mu selectively activates the mitogen-activated protein kinase (MAPK) p42 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Cellular and subcellular localization of transforming growth factor-alpha and epidermal growth factor receptor in normal and diseased human and hamster pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

An effect of K-ras gene mutation on epidermal growth factor receptor signal transduction in PANC-1 pancreatic carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Transforming growth factor alpha activates Ha-Ras in human pancreatic cancer cells with Ki-ras mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Ecdysone-inducible gene expression in mammalian cells and transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Bryostatin 1 induces biphasic activation of protein kinase D in intact cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

Activation of protein kinase D by signaling through the alpha subunit of the heterotrimeric G protein G(q).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900268-7

10.1016/S0006-291X(03)00268-7

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

12646240